Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.

Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA

doi:10.1007/s10549-025-07880-7

← 뒤로

Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.

Breast cancer research and treatment 2026 Vol.215(2) p. 62

Fumarola C, Caffarra C, La Monica S, Galetti M, Alfieri RR, Cavazzoni A, Galvani E, Generali D, Petronini PG, Bonelli MA

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Fumarola C, Caffarra C, et al. (2026). Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.. Breast cancer research and treatment, 215(2), 62. https://doi.org/10.1007/s10549-025-07880-7

MLA Fumarola C, et al.. "Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.." Breast cancer research and treatment, vol. 215, no. 2, 2026, pp. 62.

PMID 41579206

DOI 10.1007/s10549-025-07880-7

같은 제1저자의 인용 많은 논문 (1)

Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
Oncotarget 2026